{"nct_id":"NCT00853047","title":"Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2009-03","start_date_type":null,"primary_completion_date":"2014-06","primary_completion_date_type":"ACTUAL","completion_date":"2014-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LXRX"]}